# Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS)

> **NCT04503057** · — · UNKNOWN · sponsor: **Lund University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Covid19
- ARDS, Human
- ALI

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04503057
- **Lead sponsor:** Lund University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04503057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04503057, "Exhaled Breath Particles as a Clinical Indicator for Lung Injury and Acute Respiratory Distress Syndrome (ARDS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04503057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*